COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
been considered a public health emergency, extensively investigated by researchers …

In this review, we discuss the pathophysiologic and management aspects of acute
sarcopenia in relation to SARS-CoV-2 infection. COVID-19 is as a multi-organ infectious …

Following acute coronavirus disease 2019 (COVID-19), a substantial proportion of patients
showed symptoms and sequelae for several months, namely the postacute sequelae of …

Background and purpose Among post‐COVID‐19 symptoms, fatigue is reported as one of
the most common, even after mild acute infection, and as the cause of fatigue, myopathy …

Introduction: COVID-19-associated muscular complications may comprise myalgia,
weakness, wasting, and rhabdomyolysis. Skeletal muscle damage in COVID-19 may be due …

SARS-CoV-2 infection is often associated with severe inflammation, oxidative stress,
hypoxia and impaired physical activity. These factors all together contribute to muscle …

Background Chronic disease causes skeletal muscle loss that contributes to morbidity and
mortality. There are limited data on the impact of dynamic muscle loss on clinical outcomes …

In this article we review complications to the peripheral nervous system that occur as a
consequence of viral infections, with a special focus on complications of severe acute …

The long-term sequelae of the coronavirus disease 2019 (COVID-19) are multifaceted and,
besides the lungs, impact other organs and tissues, even in cases of mild infection. Along …

Understanding the impact of COVID-19 on muscle strength may help to elucidate the organ
systems that contribute to acute and chronic COVID-19 sequelae. We questioned whether …